These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27686941)
21. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies. Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183 [TBL] [Abstract][Full Text] [Related]
22. Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings. Mulhbacher J; Ispas-Szabo P; Lenaerts V; Mateescu MA J Control Release; 2001 Sep; 76(1-2):51-8. PubMed ID: 11532312 [TBL] [Abstract][Full Text] [Related]
23. Dissolution difference between acidic and neutral media of acetaminophen tablets containing a super disintegrant and a soluble excipient. II. Chen CR; Cho SL; Lin CK; Lin YH; Chiang ST; Wu HL Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):478-81. PubMed ID: 9549889 [TBL] [Abstract][Full Text] [Related]
24. Carboxylated high amylose starch as pharmaceutical excipients. Structural insights and formulation of pancreatic enzymes. Massicotte LP; Baille WE; Mateescu MA Int J Pharm; 2008 May; 356(1-2):212-23. PubMed ID: 18403141 [TBL] [Abstract][Full Text] [Related]
25. Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution. Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N Int J Pharm; 2020 Mar; 577():119080. PubMed ID: 31988030 [TBL] [Abstract][Full Text] [Related]
26. A novel zein-based dry coating tablet design for zero-order release. Guo HX; Shi YP Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825 [TBL] [Abstract][Full Text] [Related]
27. Self-stabilized chitosan and its complexes with carboxymethyl starch as excipients in drug delivery. Leonida M; Ispas-Szabo P; Mateescu MA Bioact Mater; 2018 Sep; 3(3):334-340. PubMed ID: 29988516 [TBL] [Abstract][Full Text] [Related]
28. Tableting of hot-melt coated paracetamol granules: Material tableting properties and quality characteristics of the obtained tablets. Milanovic A; Aleksic I; Ibric S; Parojcic J; Cvijic S Eur J Pharm Sci; 2020 Jan; 142():105121. PubMed ID: 31669762 [TBL] [Abstract][Full Text] [Related]
29. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. Cao QR; Choi YW; Cui JH; Lee BJ J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656 [TBL] [Abstract][Full Text] [Related]
30. Carboxymethyl starch mucoadhesive microspheres as gastroretentive dosage form. Lemieux M; Gosselin P; Mateescu MA Int J Pharm; 2015 Dec; 496(2):497-508. PubMed ID: 26456246 [TBL] [Abstract][Full Text] [Related]
31. Formulation development and evaluation of lamivudine controlled release tablets using cross-linked sago starch. Singh AV; Nath LK Expert Opin Drug Deliv; 2013 Feb; 10(2):173-82. PubMed ID: 23241031 [TBL] [Abstract][Full Text] [Related]
32. Cross-linked high amylose starch derivatives for drug release III. Diffusion properties. Mulhbacher J; Mateescu MA Int J Pharm; 2005 Jun; 297(1-2):22-9. PubMed ID: 15878244 [TBL] [Abstract][Full Text] [Related]
33. Modulation of a pulsatile release drug delivery system using different swellable/rupturable materials. El-Maradny HA Drug Deliv; 2007 Nov; 14(8):539-46. PubMed ID: 18027184 [TBL] [Abstract][Full Text] [Related]
34. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium]. Kołodziejczyk MK; Kołodziejska J; Zgoda MM Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443 [TBL] [Abstract][Full Text] [Related]
35. Partial least square projections to latent structures analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets. Korhonen O; Matero S; Poso A; Ketolainen J J Pharm Sci; 2005 Dec; 94(12):2716-30. PubMed ID: 16258997 [TBL] [Abstract][Full Text] [Related]
36. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release. Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548 [TBL] [Abstract][Full Text] [Related]
37. Recent advances of starch-based excipients used in extended-release tablets: a review. Hong Y; Liu G; Gu Z Drug Deliv; 2016; 23(1):12-20. PubMed ID: 24833274 [TBL] [Abstract][Full Text] [Related]
38. Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery. Pringels E; Ameye D; Vervaet C; Foreman P; Remon JP J Control Release; 2005 Apr; 103(3):635-41. PubMed ID: 15820410 [TBL] [Abstract][Full Text] [Related]
39. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications. Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316 [TBL] [Abstract][Full Text] [Related]
40. Carboxymethyl Starch Films as Enteric Coatings: Processing and Mechanistic Insights. Labelle MA; Ispas-Szabo P; Vilotte F; Mateescu MA J Pharm Sci; 2024 Mar; 113(3):725-734. PubMed ID: 37690776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]